MAM
Dentsu Communications bags TVS Jupiter
MUMBAI: TVS Motor Company has announced that it has appointed Dentsu Communications to handle its recently launched TVS Jupiter brand. This will be in addition to the already existing WEGO brand that the agency handles.
Commenting on bagging the new account, Dentsu Communications CEO Arijit Ray said, “We are absolutely delighted to be assigned the communication duties for Jupiter. TVS is one of our most prestigious portfolios and we are really happy to have won the second assignment within a year. It is truly a measure of the quality of work and engagement put forth by Team Bangalore over the last year, and the collective understanding of the agency of the automotive space. Jupiter is a fantastic product and seeks to build a great slot in the market. We have had a good time interacting with the team at TVS and the Bangalore Team is really looking forward to some exciting times ahead on Brand Jupiter.”
 |
|---|
|
Jupiter is a fantastic product and seeks to build a great slot in the market believes Arijit Ray
|
Dentsu Communications will work on various campaigns for TVS Jupiter and will be responsible for the account’s campaign planning and creative executions across Television and Print mediums.
“Effective communication in today’s cluttered automotive world is essential in order to establish a brand and Dentsu Communications has been able to do that very effectively for our Wego brand. We are confident that with the backing of their Wego experience and the understanding of TVS Motor Company’s philosophy, they will be able to create a niche positioning for TVS Jupiter as well with some spectacular campaigns,” said TVS Motor Company GM- marketing Aniruddha Halder .
MAM
Cipla appoints Achin Gupta as MD and global CEO
Veteran pharma leader with 20-plus years takes charge from 1 April 2026, succeeding current MD.
MUMBAI: Cipla’s next chapter just got a seasoned prescription because when it comes to leading a pharma giant, Achin Gupta knows exactly which dose delivers results. The Mumbai-based drugmaker announced on 23 February 2026 that Achin Gupta, currently global chief operating officer, will step up as managing director and global chief executive officer from 1 April 2026. He succeeds the outgoing leadership team and will steer Cipla’s worldwide operations, market expansion, operational efficiency, and innovation pipeline across its broad portfolio of generics, specialty drugs, and consumer healthcare treatments.
Gupta brings more than 20 years of pharmaceutical industry experience to the corner office. Before rejoining Cipla, he spent over eight years at Glenmark Pharmaceuticals in senior roles, having also worked there earlier between 2004 and 2012. His career path also includes key stints at Abbott Laboratories and management consulting firm A.T. Kearney, giving him a well-rounded view of global pharma strategy, operations, and growth.
In his current COO role, Gupta has already been deeply involved in streamlining Cipla’s supply chain, boosting manufacturing agility, and driving digital transformation moves that positioned the company strongly amid post-pandemic supply challenges and rising competition. As MD and Global CEO, he’ll now have full accountability for executing Cipla’s long-term vision, from deepening presence in key markets like the US, Europe, and emerging regions to accelerating R&D in complex generics and biosimilars.
The appointment comes at a pivotal time for Cipla, as the industry navigates pricing pressures, regulatory shifts, and the push for affordable innovation in chronic therapies. Gupta’s track record of scaling operations and delivering consistent performance makes him a logical internal choice to keep the momentum going.
For a company that’s long been a household name in affordable medicines, this leadership handoff is less about a big shake-up and more about steady continuity with fresh energy ensuring the next dose of growth is as effective as the last.
